Skip to main content

Table 2 Clinical outcome up to 1-year

From: Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation

 

Low (n = 960)

High (n = 977)

Hazard ratio (95% CI)

P value

Death

5 (0.52)

8 (0.82)

1.57 (0.52 to 4.79)

0.580

 Cardiovascular death

3 (0.31)

6 (0.61)

1.97 (0.49 to 7.84)

0.329

Myocardial infarction

13 (1.35)

22 (2.25)

1.66 (0.84 to 3.28)

0.172

 STEMI

8 (0.83)

19 (1.94)

2.33 (1.03 to 5.31)

0.051

 NSTEMI

3 (0.31)

3 (0.31)

0.98 (0.20 to 4.86)

1.000

TLR

85 (8.86)

124 (12.69)

1.43 (1.10 to 1.86)

0.007

Stent thrombosis

13 (1.35)

27 (2.76)

2.04 (1.06 to 3.93)

0.037

MACE

114 (11.88)

179 (18.32)

1.54 (1.24 to 1.91)

<  0.001

Bleeding events

93 (9.69)

102 (10.44)

1.08 (0.83 to 1.41)

0.598

  1. CI Confidence interval, NSTEMI Non-ST elevation myocardial infarction, STEMI ST elevation myocardial infarction, TLR Target lesion revascularization, MACE Major adverse cardiac events; Other abbreviations as in Table 1
  2. Data are presented as n (%)